Showing results (11-20 of 383) with videos related to

Sort By:
Pageof 39
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 31, 2012
The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinomaIsil Z Yildiz-Aktas, David J Dabbs, Rohit Bhargava
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 24, 2009
PAX 2: a novel Müllerian marker for serous papillary carcinomas to differentiate from micropapillary breast carcinomaMamatha Chivukula, David J Dabbs, Siobhan O'Connor, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 31, 2006
Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profileDavid J Dabbs, Mamatha Chivukula, Gloria Carter, et al.
International Journal of Surgical Pathology|April 18, 2009
Basal-like subtype breast cancers in women older than 40 years of ageCağatay Erşahin, Mamatha Chivukula, Rohit Bhargava, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 11, 2011
Insulin-like growth factor receptor-1 (IGF-1R) expression in normal breast, proliferative breast lesions, and breast carcinomaRohit Bhargava, Sushil Beriwal, Kim McManus, et al.
American Journal of Clinical Pathology|October 16, 2008
CK5 is more sensitive than CK5/6 in identifying the "basal-like" phenotype of breast carcinomaRohit Bhargava, Sushil Beriwal, Kim McManus, et al.
American Journal of Clinical Pathology|February 20, 2015
Dual HER2 gene protein assay: focused study of breast cancers with 2+ immunohistochemical expressionZaibo Li, David J Dabbs, Kristine L Cooper, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 21, 2012
Morphologic features do not influence response to trastuzumab-containing neoadjuvant chemotherapy in HER2-positive breast cancerXin Li, Amal Kanbour-Shakir, David J Dabbs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 4, 2012
Semi-quantitative immunohistochemical assay versus oncotype DX(®) qRT-PCR assay for estrogen and progesterone receptors: an independent quality assurance studyJames A Kraus, David J Dabbs, Sushil Beriwal, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 27, 2010
Concordance between semiquantitative immunohistochemical assay and oncotype DX RT-PCR assay for estrogen and progesterone receptorsSiobhan M O'Connor, Sushil Beriwal, David J Dabbs, et al.
Pageof 39